Asghar Rana Jawad, Patlan David E, Miner Mark C, Rhodes Halsey D, Solages Anthony, Katz Dolly J, Beall David S, Ijaz Kashef, Oeltmann John E
Epidemic Intelligence Service, Office of Workforce and Career Development and Division of Global Public Health Capacity Development, Centers for Disease Control and Prevention, Atlanta, GA, USA.
J Urban Health. 2009 Sep;86(5):776-80. doi: 10.1007/s11524-009-9378-z. Epub 2009 Jun 16.
Persons named by a patient with tuberculosis (TB) are the focus of traditional TB contact investigations. However, patients who use illicit drugs are often reluctant to name contacts. Between January 2004 and May 2005, 18 isoniazid-resistant TB cases with matching Mycobacterium tuberculosis genotypes (spoligotypes) were reported in Miami; most patients frequented crack houses and did not name potentially infected contacts. We reviewed medical records and re-interviewed patients about contacts and locations frequented to describe transmission patterns and make recommendations to control TB in this population. Observed contacts were not named but were encountered at the same crack houses as the patients. Contacts were evaluated for latent TB infection with a tuberculosis skin test (TST). All 18 patients had pulmonary TB. Twelve (67%) reported crack use and 14 (78%) any illicit drug use. Of the 187 contacts evaluated, 91 (49%) were named, 16 (8%) attended a church reported by a patient, 61 (33%) used a dialysis center reported by a patient, and 19 (10%) were observed contacts at local crack houses. Compared to named contacts, observed contacts were eight times as likely to have positive TST results (relative risk = 7.8; 95% confidence interval = 3.8-16.1). Dialysis center and church contacts had no elevated risk of a positive TST result. Testing observed contacts may provide a higher yield than traditional name-based contact investigations for tuberculosis patients who use illicit drugs or frequent venues characterized by illicit drug use.
结核病(TB)患者所提及的人员是传统结核病接触者调查的重点对象。然而,使用非法药物的患者往往不愿说出接触者。在2004年1月至2005年5月期间,迈阿密报告了18例具有匹配结核分枝杆菌基因型(寡核苷酸分型)的耐异烟肼结核病病例;大多数患者常去吸食强效纯可卡因的场所,且未说出可能受感染的接触者。我们查阅了病历,并就接触者和常去场所重新询问了患者,以描述传播模式,并提出在该人群中控制结核病的建议。观察到的接触者并非患者说出的,但却是在与患者相同的吸食强效纯可卡因场所遇到的。通过结核菌素皮肤试验(TST)对接触者进行潜伏性结核感染评估。所有18例患者均患有肺结核。12例(67%)报告吸食强效纯可卡因,14例(78%)使用任何非法药物。在接受评估的187名接触者中,91名(49%)是患者说出的,16名(8%)去过患者报告的教堂,61名(33%)使用过患者报告的透析中心,19名(10%)是在当地吸食强效纯可卡因场所观察到的接触者。与说出的接触者相比,观察到的接触者TST结果呈阳性的可能性高出8倍(相对风险=7.8;95%置信区间=3.8 - 16.1)。透析中心和教堂接触者TST结果呈阳性的风险并未升高。对于使用非法药物或常去有非法药物使用特征场所的结核病患者,检测观察到的接触者可能比传统的基于说出名字的接触者调查有更高的检出率。